|
Alexandros Spyridonidis MD, PhD
Professor of Hematology and Director
BMT Unit and Institute of Cell Therapy
Patras
Greece
|
Spyridonidis Alexandros was born in Greece and studied medicine (MD) in Aristotle U of
Thessaloniki, Greece. He was trained as hematologist in the Dept. of Hematology & Oncology
of U of Freiburg, Germany where he completed his PhD thesis and awarded the Venia Legendi.
He was appointed as Professor of Hematology in U of Patras, Greece where he established
and is currently the Director of the Bone Marrow Transplantation (www.bmtpatra.gr), the first
in Greece “Centre of Bone Marrow Donor Volunteers U Patras (CBMDP)” (www.xarisezoi.gr),
the “Institute of Cellular Therapy” (www.ictpatras.gr) and the international MSc Program “Cell
and Gene Therapies: from Bench to Bedside and Good Manufacturing Practices“
(www.mastercgt.com). He has spent a research sabbatical leave at the NIH, USA (Prof. J.
Barrett’s) working on the clinical establishment of cell therapies. The pipeline of his clinical
translational research includes the preclinical and clinical GMP manufacture of an academic
Cell Therapy Product (iG-Tregs) which is now evaluated in a Phase I/II study (EudraCT-2021-
006367-26). He is/was Board Member of the Hellenic Society of Hematology (HSH), Founding
and Board Member of the “Hellenic Society of Gene Therapy and Regenerative Medicine”,
Board Member of the Hellenic National Transplant Organization, President of the BMT
Scientific Group of the HSH and Board Member of the Scientific Council of the Prefecture of
Western Greece. Outside Greece, he is/was Hellenic Representative in European Union in
“Tissues and Cells” Section, Co-leader of the RIC-Committee of Acute Leukemia WP of EBMT,
Board Member of the “Centre of the Study of Haematological Malignancies” in Cyprous,
Inspector of the JACIE/EBMT for Cell Therapies and Mentor at the H-Net Masterclass of the
European Haematology Association (EHA). He has multiple publications, including a “How I
treat” in Blood, and has received numerous of national and international awards and research
grants from multiple sources, mainly in the field of leukemia and cellular therapy.
Dr. SPYRIDONIDIS ALEXANDROS, MD, PhD
Professor of Hematology
Director of Bone Marrow Transplantation Unit
Director Institute of Cell Therapy
Director CBMDP, Bone Marrow Donor Center
Director MSc “Cell and Gene Therapies”
Leader RIC Committee Acute Leukemia WP EBMT,
Hellenic Representative, European Union, "Tissues and Cells"
JACIE Inspector for Cell Therapy
University of Patras, Greece, spyridonidis@upatras.gr
Thessaloniki, Greece. He was trained as hematologist in the Dept. of Hematology & Oncology
of U of Freiburg, Germany where he completed his PhD thesis and awarded the Venia Legendi.
He was appointed as Professor of Hematology in U of Patras, Greece where he established
and is currently the Director of the Bone Marrow Transplantation (www.bmtpatra.gr), the first
in Greece “Centre of Bone Marrow Donor Volunteers U Patras (CBMDP)” (www.xarisezoi.gr),
the “Institute of Cellular Therapy” (www.ictpatras.gr) and the international MSc Program “Cell
and Gene Therapies: from Bench to Bedside and Good Manufacturing Practices“
(www.mastercgt.com). He has spent a research sabbatical leave at the NIH, USA (Prof. J.
Barrett’s) working on the clinical establishment of cell therapies. The pipeline of his clinical
translational research includes the preclinical and clinical GMP manufacture of an academic
Cell Therapy Product (iG-Tregs) which is now evaluated in a Phase I/II study (EudraCT-2021-
006367-26). He is/was Board Member of the Hellenic Society of Hematology (HSH), Founding
and Board Member of the “Hellenic Society of Gene Therapy and Regenerative Medicine”,
Board Member of the Hellenic National Transplant Organization, President of the BMT
Scientific Group of the HSH and Board Member of the Scientific Council of the Prefecture of
Western Greece. Outside Greece, he is/was Hellenic Representative in European Union in
“Tissues and Cells” Section, Co-leader of the RIC-Committee of Acute Leukemia WP of EBMT,
Board Member of the “Centre of the Study of Haematological Malignancies” in Cyprous,
Inspector of the JACIE/EBMT for Cell Therapies and Mentor at the H-Net Masterclass of the
European Haematology Association (EHA). He has multiple publications, including a “How I
treat” in Blood, and has received numerous of national and international awards and research
grants from multiple sources, mainly in the field of leukemia and cellular therapy.
Dr. SPYRIDONIDIS ALEXANDROS, MD, PhD
Professor of Hematology
Director of Bone Marrow Transplantation Unit
Director Institute of Cell Therapy
Director CBMDP, Bone Marrow Donor Center
Director MSc “Cell and Gene Therapies”
Leader RIC Committee Acute Leukemia WP EBMT,
Hellenic Representative, European Union, "Tissues and Cells"
JACIE Inspector for Cell Therapy
University of Patras, Greece, spyridonidis@upatras.gr